Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticotropin-releasing hormone receptor 1 (CRHR1) is a membrane-bound G protein-coupled receptor of the class B secretin family, composed of 7 transmembrane helices. Primarily found in the brain, pituitary, and other tissues, it is activated by corticotropin-releasing hormone (CRH) and related peptides, initiating a cascade that regulates the neuroendocrine, behavioral, and immune responses to stress, notably by activating the hypothalamic–pituitary–adrenal (HPA) axis via cAMP and other signaling pathways. CRHR1 is a major molecular target in research and development for stress, anxiety, depression, and several other disorders, though therapeutic development has been challenging, mostly due to difficulties in achieving receptor selectivity, CNS penetration, and adequate safety profile.
Antagonists block CRHR1 and inhibit binding/activation by corticotropin-releasing factor (CRF) and related peptides (urocortins), suppressing downstream signaling (e.g. cAMP production, stress response). Agonists (less clinically relevant): stimulate CRHR1, activating HPA axis and stress response pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-releasing hormone receptor type 1 (CRHR1).